Granahan Investment Management’s AngioDynamics ANGO Stock Holding History

Granahan Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-416,200	Closed	-$7.67M	–	182
2019 Q3	$7.67M	Buy	416,200 +26,924	+7%	+$527K	0.42%	69
2019 Q2	$7.67M	Sell	389,276 -6,864	-2%	-$140K	0.38%	71
2019 Q1	$9.06M	Sell	396,140 -82,547	-17%	-$1.79M	0.49%	61
2018 Q4	$9.64M	Sell	478,687 -8,509	-2%	-$176K	0.68%	53
2018 Q3	$10.6M	Buy	487,196 +19,097	+4%	+$424K	0.57%	56
2018 Q2	$10.4M	Buy	468,099 +54,794	+13%	+$1.12M	0.63%	51
2018 Q1	$7.13M	Buy	413,305 +22,585	+6%	+$377K	0.51%	66
2017 Q4	$6.5M	Buy	+390,720	New	+$6.67M	0.51%	69

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Granahan Investment Management's ANGO Position: Q4 2019 in Review

Granahan Investment Management sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 416,200 shares — an estimated $7.67M sold.

Granahan Investment Management first reported a position in ANGO in Q4 2017 and held it in 8 quarters. The position peaked at $10.6M in Q3 2018. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

Granahan Investment Management reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
Granahan Investment Management sold 416,200 AngioDynamics shares in Q4 2019, an estimated $7.67M.
Granahan Investment Management first reported a position in AngioDynamics in Q4 2017 and held it in 8 quarters.
Granahan Investment Management's AngioDynamics position peaked at $10.6M in Q3 2018.
157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Granahan Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.